Zemplar Dosage
Generic name: PARICALCITOL 2ug
Dosage form: capsule, liquid filled
Drug class: Vitamins
Medically reviewed by Drugs.com. Last updated on Aug 7, 2024.
2.1 Chronic Kidney Disease Stages 3 and 4 in Adults
Administer ZEMPLAR capsules orally once daily or three times a week. When dosing three times weekly, do not administer more frequently than every other day.
Initial Dose
Baseline iPTH Level | Daily Dose | Three Times a Week Dose* |
Less than or equal to 500 pg/mL | 1 mcg | 2 mcg |
More than 500 pg/mL | 2 mcg | 4 mcg |
* To be administered not more often than every other day |
Dose Titration
Dose Adjustment at 2 to 4 Week Intervals | |||
iPTH Level Relative to Baseline | ZEMPLAR Capsule Dose | Daily Dosage | Three Times a Week Dosage* |
The same, increased or decreased by less than 30% |
Increase dose by | 1 mcg | 2 mcg |
Decreased by more than or equal to 30% and less than or equal to 60% | Maintain dose | - | - |
Decreased by more than 60% or iPTH less than 60 pg/mL |
Decrease dose by | 1 mcg | 2 mcg |
* To be administered not more often than every other day |
If a patient is taking the lowest dose, 1 mcg, on the daily regimen and a dose reduction is needed, the dose can be decreased to 1 mcg three times a week. If a further dose reduction is required, the drug should be withheld as needed and restarted at a lower dosing frequency.
2.2 Chronic Kidney Disease Stage 5 in Adults
Initial Dose
Administer the dose of ZEMPLAR capsules orally three times a week, no more frequently than every other day based upon the following formula:
Dose (micrograms) = baseline iPTH (pg/mL) divided by 80
Treat patients only after their baseline serum calcium has been adjusted to 9.5 mg/dL or lower to minimize the risk of hypercalcemia.
Dose Titration
Individualize the dose of ZEMPLAR based on iPTH, serum calcium and phosphorus levels. Titrate ZEMPLAR dose based on the following formula:
Dose (micrograms) = most recent iPTH level (pg/ml) divided by 80
If serum calcium is elevated, the dose should be decreased by 2 to 4 micrograms.
As iPTH approaches the target range, small, individualized dose adjustments may be necessary in order to achieve a stable iPTH. In situations where monitoring of iPTH, Ca or P occurs less frequently than once per week, a more modest initial and dose titration ratio (e.g., iPTH divided by 100) may be warranted.
2.3 Pediatric Patients (Ages 10 to 16 Years)
CKD Stages 3 and 4
Initial Dose
Administer ZEMPLAR 1 mcg capsule orally three times a week, no more frequently than every other day.
Dose Titration
Individualize and titrate ZEMPLAR dose based on iPTH, serum calcium and phosphorus levels to maintain an iPTH level within target range.
Every 4 weeks, each administered ZEMPLAR dose may be increased in 1 mcg increments, maintaining the three times per week regimen (e.g., increase from 1 mcg three times per week to 2 mcg three times per week). At any time, each administered dose may be decreased by 1 mcg. ZEMPLAR may be stopped if the patient requires reduction while receiving 1 mcg three times per week, resuming when appropriate.
CKD Stage 5
Initial Dose
Administer the dose of ZEMPLAR capsules orally three times a week, no more frequently than every other day based upon the following formula:
Dose* (micrograms) = baseline iPTH (pg/mL) divided by 120
* Round down to the nearest whole number
Dose Titration
Subsequent dosing should be individualized and based on iPTH, serum calcium and phosphorus levels to maintain an iPTH level within target range.
Every 4 weeks, each administered ZEMPLAR dose may be increased in 1 mcg increments, maintaining the three times per week regimen (e.g., increase from 1 mcg three times per week to 2 mcg three times per week). At any time, each administered dose may be decreased by 2 mcg. ZEMPLAR may be stopped if the patient requires reduction while receiving 2 mcg three times per week or 1 mcg three times per week, resuming when appropriate.
2.4 Monitoring
Monitor serum calcium and phosphorus levels closely after initiation of ZEMPLAR, during dose titration periods and during co-administration with strong CYP3A inhibitors.
If hypercalcemia is observed, the dose of ZEMPLAR should be reduced or withheld until these parameters are normalized.
More about Zemplar (paricalcitol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- Generic availability
- Drug class: vitamins
- En español
Patient resources
- Zemplar drug information
- Zemplar (Paricalcitol Intravenous) (Advanced Reading)
- Zemplar (Paricalcitol Oral) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.